United Therapeutics
UTHR
UTHR
410 hedge funds and large institutions have $6.46B invested in United Therapeutics in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 153 increasing their positions, 142 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
410
Holders Change
+5
Holders Change %
+1.23%
% of All Funds
10.22%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
52
Increased
153
Reduced
142
Closed
40
Calls
$82.5M
Puts
$85.8M
Net Calls
-$3.27M
Net Calls Change
+$3.66M
Top Buyers
| 1 |
BlackRock
New York
|
+$627M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$51.1M |
| 3 |
Goldman Sachs
New York
|
+$38.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.7M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$29.1M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$119M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$41.6M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$34.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34.1M |
| 5 |
STMM
South Texas Money Management
San Antonio,
Texas
|
-$26.8M |
